Evidence map›Paper›PMID 42558638›Full record

ReviewFrontiers in cellular and infection microbiology2026

Advances in the molecular pathogenesis of

Zheng-Wei Sun, Yi-Ming Guo, Lu Ye

Abstract readReview
In one paragraph

Review in Frontiers in cellular and infection microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Zheng-Wei SunSchool of Medicine, Northwest University, Xi'an, Shaanxi, China.
Yi-Ming GuoXi'an People's Hospital (Xi'an Fourth Hospital), Affiliated People's Hospital of Northwest University, Xi'an, Shaanxi, China.
Lu YeSchool of Medicine, Northwest University, Xi'an, Shaanxi, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nocardia keratitis is an infectious ocular disease that poses substantial diagnostic and therapeutic challenges worldwide. It occurs predominantly in individuals with corneal barrier disruption, contact lens wear, or impaired host immunity. Due to its relatively insidious onset, the clinical manifestations are nonspecific, and laboratory diagnosis is technically demanding. As a result, delayed identification and suboptimal treatment are common, often resulting in poor visual outcomes. Although diagnostic and therapeutic techniques have improved in recent years, a comprehensive understanding of Nocardia virulence mechanisms and their complex, dynamic interactions with the host immune system remains to be fully established. Therefore, starting from the temporal sequence of infection and the dynamic host-pathogen interplay, we integrate scattered observations into a pathological framework that traces the transition from colonization to immune dysregulation and ultimately to tissue damage. This review systematically outlines the major virulence factors of Nocardia implicated in the stages of adhesion and colonization, tissue invasion, and intracellular survival. It also discusses the dual role of neutrophils, emerging evidence for pyroptosis, apoptosis, and necroptosis (PANoptosis)-related signaling pathways, and the impact of host immune status on disease susceptibility. This work aims to provide a mechanistic basis for investigating the pathogenesis of Nocardia keratitis, optimizing its diagnosis, and developing targeted therapeutic strategies.

Indexed as

Host-Pathogen InteractionsKeratitisNocardiaNocardia InfectionsAnimalsBacterial AdhesionHumansVirulence FactorsVirulence Factorshost immunityhost-pathogen interactionmolecular mechanismsNocardia keratitisPANoptosisvirulence factors

Identifiers

PMID42558638
PMCPMC13437976

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.